BackLandos Biopharma Overview

Landos Biopharma Total Liabilities

Landos Biopharma's total liabilities is $6.7M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$6.74M
62.07% YoYΔ $2.58M vs prior year quarter

Peer trimmed avg / median

Loading

Landos Biopharma Total Liabilities History

Loading

Landos Biopharma vs. peers: Total Liabilities Comparison

Loading

Landos Biopharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Landos Biopharma (LABP) FAQ

As of the most recent data (March 2024), LABP shows a total liabilities of $6.7M. That compares with $4.2M in the prior-year period — up 62.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LABP's total liabilities is now $6.7M (was $4.2M) — a 62.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Landos Biopharma is outperforming or lagging.

Tracking LABP's total liabilities over time shows whether Landos Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $6.7M That compares with $4.2M in the prior-year period — up 62.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Landos Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $6.7M) with ownership activity and broader fundamentals.

Landos Biopharma's total liabilities is $6.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.